Patents by Inventor Zeeshan Khawaja

Zeeshan Khawaja has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THERAPEUTIC METHODS USING VADADUSTAT
    Publication number: 20240325360
    Abstract: This invention provides methods for the treatment of anemia in patients with chronic kidney disease (CKD) using vadadustat (Compound 1). Methods described herein provide alternative dosing regimens for patients having anemia. In addition, methods herein are suitable for patients converting from a previous anemia treatment including erythropoietin stimulating agent (ESA), patients who are on dialysis (e.g., peritoneal dialysis or hemodialysis), or CKD patients having certain hemoglobin (Hb) levels.
    Type: Application
    Filed: January 7, 2022
    Publication date: October 3, 2024
    Applicant: Akebia Therapeutics, Inc.
    Inventors: Steven BURKE, Ajit CHAVAN, Zeeshan KHAWAJA
  • METHODS OF TREATING COMPLEMENT MEDIATED THROMBOTIC MICROANGIOPATHY USING AN ANTI-C5 ANTIBODY
    Publication number: 20240092881
    Abstract: Provided are methods for clinical treatment of complement-mediated TMA (CM-TMA) (e.g., CM-TMA associated with a trigger, such as autoimmune condition, an infection, a transplant, one or more drugs, or malignant hypertension), using an anti-C5 antibody, or antigen binding fragment thereof, such as ravulizumab (ULTOMIRIS®).
    Type: Application
    Filed: January 18, 2022
    Publication date: March 21, 2024
    Applicant: Alexion Pharmaceuticals, Inc.
    Inventors: Gin-Fu Chen, Zeeshan Khawaja